Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1245821.RAbse54lS849hPe7iIJX1-ugWTWgyMK52FQUoQsTm9xhk130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1245821.RAbse54lS849hPe7iIJX1-ugWTWgyMK52FQUoQsTm9xhk130_assertion type Assertion NP1245821.RAbse54lS849hPe7iIJX1-ugWTWgyMK52FQUoQsTm9xhk130_head.
- NP1245821.RAbse54lS849hPe7iIJX1-ugWTWgyMK52FQUoQsTm9xhk130_assertion description "[Here the CEA and CD3 bispecific single-chain antibody MEDI-565 (also known as MT111 and AMG 211) was evaluated for its ability to activate T cells both in vitro and in vivo and to kill human tumor cell lines harboring various somatic mutations commonly found in colorectal cancers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1245821.RAbse54lS849hPe7iIJX1-ugWTWgyMK52FQUoQsTm9xhk130_provenance.
- NP1245821.RAbse54lS849hPe7iIJX1-ugWTWgyMK52FQUoQsTm9xhk130_assertion evidence source_evidence_literature NP1245821.RAbse54lS849hPe7iIJX1-ugWTWgyMK52FQUoQsTm9xhk130_provenance.
- NP1245821.RAbse54lS849hPe7iIJX1-ugWTWgyMK52FQUoQsTm9xhk130_assertion SIO_000772 25484061 NP1245821.RAbse54lS849hPe7iIJX1-ugWTWgyMK52FQUoQsTm9xhk130_provenance.
- NP1245821.RAbse54lS849hPe7iIJX1-ugWTWgyMK52FQUoQsTm9xhk130_assertion wasDerivedFrom befree-2016 NP1245821.RAbse54lS849hPe7iIJX1-ugWTWgyMK52FQUoQsTm9xhk130_provenance.
- NP1245821.RAbse54lS849hPe7iIJX1-ugWTWgyMK52FQUoQsTm9xhk130_assertion wasGeneratedBy ECO_0000203 NP1245821.RAbse54lS849hPe7iIJX1-ugWTWgyMK52FQUoQsTm9xhk130_provenance.